Jasbani Dayal

Biography

·         Postdoctoral researcher: University of Dundee, Feb 2011- present ·         PhD: University of Dundee, UK: February 2011 ·         Master of Science in Biotechnology: University of Abertay Dundee, UK: November, 2005 ·         Bachelor of Science (Honours) Biotechnology: Amity Institute of Biotechnology (Chaudhary Charan Singh University, Meerut), India: August, 2004. Award: 1st ·         Senior Secondary Certificate Examination: Mater Dei School, Delhi (India): July, 2001. Award: 1st; Distinction in Chemistry      ·          Higher Secondary Certificate Examination: Mater Dei School, Delhi (India): June, 1999. Award: 1st; Distinction

Research Interest

RDEB is a rare inherited skin disorder characterized by mutation in the basement membrane associated protein, type VII collagen. RDEB patients are predisposed to developing aggressive cutaneous squamous cell carcinoma (cSCC) resulting in a 90% mortality rate by the age of 55. There are no targeted therapies available for RDEB cSCC patients and surgical intervention, chemotherapy and radiation therapy have not proved successful. Current research involves elucidating the role of TGFβ in RDEB disease progression in Dr Gareth J Inman lab.